Mobile Menu

Search Results

Search results for: inhibitor

Liquid biopsies for personalised cancer care

A team at The Institute of Cancer Research (ICR), London and The Royal Marsden NHS Foundation Trust have shown that […]

Just one base at a time

The advancements in base editing, a new genome editing approach, have generated a lot of excitement amongst scientists in recent […]

Insight into the distinct tumour immune microenvironments in gastric cancer patients

Researchers have compared the tumour immune microenvironments (TIMEs) of primary gastric cancers and found distinct patterns between primary and metastatic […]

Let’s talk about colon cancer

The recent passing of actor and role model, Chadwick Boseman, from colon cancer has shocked the nation. This shock seems […]

BRCA2 c.9227G>T variant found to be pathogenic

Recent analysis published in Scientific Reports has concluded that c.9227G>T is a BRCA2 pathogenic variant. Variants of uncertain significance The […]

MiR-93 as a potential novel target for breast cancer

A new study published in Cell Death and Disease has revealed the role of miR-93 in tumorigenesis and chemosensitivity. Breast […]

CRUK forms a new partnership to develop a head and neck cancer vaccine

Cancer Research UK (CRUK), the University of Southampton and the London-based biotechnology company Touchlight Genetics have announced a new partnership […]

New class of precision oncology drug strips cancer of its DNA defences

Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]

The impact of COVID-19 on the rare disease community

For the last few weeks, we have been covering COVID-related stories, from the sequencing of the virus, the research efforts, […]

Opinion: Precision medicine will be driven by diagnostic technologies

Earlier this week, Stephane Budel wrote an article about the role diagnostic technologies will play in the future of precision medicine. […]